 "Eris Lifesciences")
After growing organically for almost a decade, Eris Lifesciences made 4 acquisitions of distressed businesses in about a couple of years and is now hoping to turn them around.
Of the four acquisitions, Eris has managed to grow the contributions from Amay and Kindex to its revenues by a whopping 211 per cent this fiscal from FY17. The Ahmedabad-headquartered company is working actively to turn around the other two - Strides (its largest acquisition so far) and niche nutrition player UTH Healthcare.
Of the four acquisitions, Eris has managed to grow the contributions from Amay and Kindex to its revenues by a whopping 211 per cent this fiscal from FY17. The Ahmedabad-headquartered company is working actively to turn around the other two - Strides (its largest acquisition so far) and niche nutrition player UTH Healthcare.
The company paid around Rs 6.3 billion for these assets and now analysts expect these to
